Bazedoxifene, a selective estrogen receptor modulator-Reference-Cited by-同舟云学术

Bazedoxifene, a selective estrogen receptor modulator

Published:2009-11 Issue:6 Volume:16 Page:1109-1115
ISSN:1072-3714
Container-title:Menopause
language:en
Short-container-title:

Author:

Archer David F.,Pinkerton JoAnn V.,Utian Wulf H.,Menegoci José C.,de Villiers Tobie J.,Yuen Chui Kin,Levine Amy B.,Chines Arkadi A.,Constantine Ginger D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference31 articles.

1. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis.;Genant;Osteoporos Int,1999

2. Pharmacologic prevention of osteoporotic fractures.;Zizic;Am Fam Physician,2004

3. Guidelines for the management of postmenopausal osteoporosis for GPs.;O'Neill;Aust Fam Physician,2004

4. Hormone replacement therapy: to use or not to use?;Baber;Med J Aust,2003

5. Developing a SERM: stringent preclinical selection criteria leading to an acceptable candidate (WAY-140424) for clinical evaluation.;Komm;Ann N Y Acad Sci,2001

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond breast cancer: role of selective estrogen receptor modulators in reducing systemic malignancies: evidence from population-based data;Current Medical Research and Opinion;2024-08-18

2. Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers;Drug Design, Development and Therapy;2023-04

3. Biodegradable bilayer hydrogel membranes loaded with bazedoxifene attenuate blood–spinal cord barrier disruption via the NF-κB pathway after acute spinal cord injury;Acta Biomaterialia;2023-03

4. Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer;Pharmaceutics;2022-03-20

5. Postmenopausal Osteoporosis;Endocrinology and Diabetes;2022